UPDATE : Thursday, March 22, 2018
Hanall Biopharma made $81-million technology export to China by Lee Hye-seon 2017-09-13 13:23
New VC investments in bio, medical fields fall sharpest in H1 by Nam Doo-hyun 2017-09-13 13:23
Celltrion presents Herzuma’s clinical results in Europe by Lee Han-soo 2017-09-11 12:19
Kang Stem, Heraeus Medical to develop anti-arthritis drug by Lee Han-soo 2017-09-08 15:25
Pharma Research Product releases home care cosmetics by Lee Han-soo 2017-09-07 17:08
Cellivery gets research funding from US Foundation by Lee Han-soo 2017-09-07 15:00
Abclon confirms IPO at 10,000 won per share by Lee Han-soo 2017-09-07 11:48
Papers related to stem cell therapy rising worldwide by Nam Doo-hyun 2017-09-06 16:45
Wells Bio wins rights to make and sell ‘Strep A Plus’ by Lee Han-soo 2017-09-06 11:48
Samsung Bioepis wins European sales approval for Imraldi by Lee Han-soo 2017-08-25 11:53
Bio firms blame small R&D spending for low technology by Nam Doo-hyun 2017-08-24 11:31
Celltrion’s move to main stock market draws investor concern by Nam Doo-hyun 2017-08-22 17:01
Samsung Bioepis, Takeda agree to develop biosimilar drugs by Lee Han-soo 2017-08-21 20:45
iNtRON Biotechnology adds trial for super bacteria drug by Marian Chu 2017-08-21 16:15
Korea lags 3.8 years behind US in medical technology by Nam Doo-hyun 2017-08-21 12:11
‘Bio industry should prepare for Nagoya Protocol’ by Nam Doo-hyun 2017-08-17 19:57
Monsanto, ToolGen sign licensing agreement for CRISPR by Constance Williams 2017-08-17 16:32
Medytox’s botulinum toxin hits record-high sales in Q2 by Constance Williams 2017-08-16 10:29
Cha Biotech turns profitable 3 years after equity spinoff by Constance Williams 2017-08-14 16:34
‘Stress resilience research to open new bio area’ by Nam Doo-hyun 2017-08-14 16:33
Back to Top